H-1B sponsorship profile: Mersana Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Mersana Therapeutics, Inc filed 8 Labor Condition Applications covering 8 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 100% (8 certified of 8 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Mersana Therapeutics, Inc’s H-1B petitions range from $110,000 at the low end to $194,605 at the high end, with a petition-weighted average of $142,376. That range reflects the mix of occupations the company sponsors, led by Senior Associate Scientist, Biology/Immuno-Oncology (2 petitions at $110,000 avg), followed by Principal Associate Scientist, Analytical Chemistry and Associate Director- New Product Strategy. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Mersana Therapeutics, Inc is headquartered in Cambridge, MA under NAICS code 5417, and places H-1B workers across 1 state, most heavily in MA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Mersana Therapeutics, Inc ranks. By H-1B petition volume, Mersana Therapeutics, Inc is #19,368 of 119,880 employers nationally and #850 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.